Details for Patent: 6,911,461

Which drugs does patent 6,911,461 protect, and when does it expire?

Patent 6,911,461 protects BRIVIACT and is included in three NDAs.

This patent has one hundred and forty-six patent family members in forty-two countries.

Summary for Patent: 6,911,461

Title:	2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Abstract:	The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
Inventor(s):	Edmond Differding, Benoît Kenda, Bénédicte Lallemand, Alain Matagne, Philippe Michel, Patrick Pasau, Patrice Talaga
Assignee:	UCB Biopharma SRL
Application Number:	US10/693,917
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,911,461
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 6,911,461

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ucb Inc	BRIVIACT	brivaracetam	SOLUTION;INTRAVENOUS	205837-001	May 12, 2016	AP	RX	Yes	Yes			Y	Y		TREATMENT OF PARTIAL-ONSET SEIZURES AS ADJUNCTIVE THERAPY IN PATIENTS WITH EPILEPSY AGED 16 YEARS AND OLDER WITH EPILEPSY
Ucb Inc	BRIVIACT	brivaracetam	SOLUTION;INTRAVENOUS	205837-001	May 12, 2016	AP	RX	Yes	Yes			Y	Y		TREATMENT OF PARTIAL ONSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 16 YEARS AND OLDER WITH EPILEPSY
Ucb Inc	BRIVIACT	brivaracetam	SOLUTION;ORAL	205838-001	May 12, 2016	AA	RX	Yes	Yes			Y	Y		TREATMENT OF PARTIAL-ONSET SEIZURES IN PATIENTS 4 YEARS OF AGE AND OLDER
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-001	May 12, 2016	AB	RX	Yes	No			Y	Y		TREATMENT OF PARTIAL-ONSET SEIZURES IN PATIENTS 4 YEARS OF AGE AND OLDER
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-002	May 12, 2016	AB	RX	Yes	No			Y	Y		TREATMENT OF PARTIAL-ONSET SEIZURES IN PATIENTS 4 YEARS OF AGE AND OLDER
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-003	May 12, 2016	AB	RX	Yes	No			Y	Y		TREATMENT OF PARTIAL-ONSET SEIZURES IN PATIENTS 4 YEARS OF AGE AND OLDER

Foreign Priority and PCT Information for Patent: 6,911,461

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0004297	Feb 23, 2000

International Family Members for US Patent 6,911,461

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1265862		PA2016013	Lithuania
European Patent Office	1452524		300815	Netherlands
European Patent Office	1452524		CA 2016 00013	Denmark
European Patent Office	1452524		16C1001	France
European Patent Office	1452524		1690009-4	Sweden
European Patent Office	1265862		PA2016013,C1265862	Lithuania